Consulting to clients in the U.S., Europe, the U.K., and the Asia Pacific and delivered a strategy based on a deep understanding of their unique assets and their growth objectives.

​

Clients include early-stage pharmaceutical, cell-and-gene therapy, and medical device  companies.